Free tool
Oncology stocks
We cover 5 companies grouped under the Oncology theme. The median market value in the group is $70.10M. Across the group, the median move over the past trading day is +2.33%. Price change over the past year runs from +12.5% to +797.9% across the middle 80 percent of the group, with a median of +75.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 0I3Q.L | Corcept Therapeutics Incorporated | $4.54B | Mid cap | +74.96% |
| 0QXX.L | Molecular Partners AG | $79.34M | Micro cap | +17.00% |
| SAR.L | Sareum Holdings plc | $70.10M | Micro cap | +76.19% |
| CRTX.L | CRISM Therapeutics Corporation | $12.38M | Micro cap | +9.52% |
| 0NWK.L | Valerio Therapeutics Société anonyme | $10.08M | Micro cap | +1279.03% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.